Pilocarpine, Brimonidine, Oxymetazoline (PBO) Compound to Control Presbyopia Symptoms

PHASE1UnknownINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 14, 2021

Primary Completion Date

September 1, 2021

Study Completion Date

September 15, 2021

Conditions

Presbyopia

Interventions

DRUG

Pilocarpine, brimonidine, oxymetazoline, hyaluronic acid, bromfenac (PBOHB) compound

To determine the safety and efficacy of a PBOHB compound in near vision of presbyopic patients.

Trial Locations (1)

RECRUITING

Optall Vision, Mexico City